Defective homologous recombination DNA repair as therapeutic target in advanced chordoma-Reference-Cited by-同舟云学术

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Published:2019-04-09 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Gröschel Stefan,Hübschmann Daniel,Raimondi Francesco,Horak Peter^ORCID,Warsow Gregor,Fröhlich Martina,Klink Barbara^ORCID,Gieldon Laura,Hutter Barbara^ORCID,Kleinheinz Kortine^ORCID,Bonekamp David,Marschal Oliver,Chudasama Priya,Mika Jagoda,Groth Marie,Uhrig Sebastian,Krämer Stephen,Heining Christoph,Heilig Christoph E.^ORCID,Richter Daniela,Reisinger Eva,Pfütze Katrin,Eils Roland^ORCID,Wolf Stephan,von Kalle Christof,Brandts Christian,Scholl Claudia,Weichert Wilko,Richter Stephan,Bauer Sebastian,Penzel Roland,Schröck Evelin,Stenzinger Albrecht,Schlenk Richard F.,Brors Benedikt^ORCID,Russell Robert B.^ORCID,Glimm Hanno,Schlesner Matthias^ORCID,Fröhling Stefan

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09633-9.pdf

Reference43 articles.

1. Stemple, D. L. Structure and function of the notochord: an essential organ for chordate development. Development 132, 2503–2512 (2005).

2. Stacchiotti, S. et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann. Oncol. 28, 1230–1242 (2017).

3. Lebellec, L. et al. Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d’Expression Française (ANOCEF). Eur. J. Cancer 79, 119–128 (2017).

4. Colia, V. & Stacchiotti, S. Medical treatment of advanced chordomas. Eur. J. Cancer 83, 220–228 (2017).

5. Vujovic, S. et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J. Pathol. 209, 157–165 (2006).

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma;Biochemical Pharmacology;2024-08

2. Germline findings in cancer predisposing genes from a small cohort of chordoma patients;Journal of Cancer Research and Clinical Oncology;2024-05-03

3. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol;Neurosurgical Focus;2024-05

4. High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer;JCO Precision Oncology;2024-03

5. Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma;Clinical Cancer Research;2023-12-04